US2006160150A1PendingUtilityA1
Immunoassays for brain natriuretic propeptide
Est. expiryMay 31, 2008(expired)· nominal 20-yr term from priority
C12P 21/02A61P 9/08G01N 33/74C07K 14/58A61K 38/00A61P 9/12C07K 16/241C07K 14/582C07K 16/2803C07K 2317/622
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Immunoassays for the biological precursor of human brain natriuretic peptide are described.
Claims
exact text as granted — not AI-modified1 . Isolated antibodies useful for immunoassays to detect, and which specifically bind, human brain natriuretic peptide of the formula:
R 1 -Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His (SEQ ID NO: 49), or the C-terminal amides thereof; wherein R 1 is the 102 amino acid sequence shown for human BNP in FIG. 8 at positions numbered 1-99 immediately upstream of the Ser residue to which R 1 is bound, or a C-terminal portion thereof.
2 . The antibodies of claim 1 which are monoclonal antibodies.
3 . The antibodies of claim 1 which further comprise a label.
4 . A method to perform an immunoassay to detect human brain natriuretic peptide in a sample which method comprises contacting said sample with the antibodies of claim 1 and assessing the ability of said antibodies to immunoreact with any human brain natriuretic peptide contained in said sample.
5 . A kit for conducting an immunoassay to detect human brain natriuretic peptide which kit comprises the antibodies of claim 1 in containers and reagents capable of recognizing and specifically binding to said peptide or said antibodies in additional containers.Join the waitlist — get patent alerts
Track US2006160150A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.